tiprankstipranks
Trending News
More News >
Prostatype Genomics AB (DE:PGO0)
FRANKFURT:PGO0
Germany Market

Prostatype Genomics AB (PGO0) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Prostatype Genomics AB’s (PGO0) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Prostatype Genomics AB is a Buy.
Prostatype Genomics AB’s (PGO0) 20-Day exponential moving average is 0.10, while Prostatype Genomics AB’s (PGO0) share price is <€0.1, making it a Buy.
Prostatype Genomics AB’s (PGO0) 50-Day exponential moving average is 0.08, while Prostatype Genomics AB’s (PGO0) share price is <€0.1, making it a Buy.

Prostatype Genomics AB (PGO0) Pivot Points

Feb 19, 2026, 01:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.05
0.07
0.08
0.10
0.11
0.13
0.15
Fibonacci
0.07
0.08
0.09
0.10
0.11
0.12
0.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prostatype Genomics AB (PGO0) Moving Averages

Feb 19, 2026, 01:29 PM
Period
Simple
Exponential
MA5
0.10Sell
0.10Sell
MA10
0.10Buy
0.10Sell
MA20
0.11Sell
0.10Buy
MA50
0.07Buy
0.08Buy
MA100
0.05Buy
0.07Buy
MA200
0.06Buy
0.07Buy
Prostatype Genomics AB’s (PGO0) 10-Day exponential moving average is 0.10, while Prostatype Genomics AB’s (PGO0) share price is <€0.1, making it a Sell.
Prostatype Genomics AB’s (PGO0) 100-Day exponential moving average is 0.07, while Prostatype Genomics AB’s (PGO0) share price is <€0.1, making it a Buy.
Prostatype Genomics AB’s (PGO0) stock price is <€0.1 and Prostatype Genomics AB’s (PGO0) 50-day simple moving average is 0.07, creating a Buy signal.
Prostatype Genomics AB’s (PGO0) stock price is <€0.1 and Prostatype Genomics AB’s (PGO0) 100-day simple moving average is 0.05, creating a Buy signal.
Prostatype Genomics AB’s (PGO0) stock price is <€0.1 and Prostatype Genomics AB’s (PGO0) 200-day simple moving average is 0.06, creating a Buy signal.

Prostatype Genomics AB (PGO0) Technical Indicators

Feb 19, 2026, 01:29 PM
Name
Value
Implied Action
RSI (14)
53.65
Neutral
STOCH (9,6)
76.91
Neutral
STOCHRSI (14)
57.96
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
38.05
Neutral
Williams %R
-45.24
Buy
CCI (14)
-49.01
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
81.02
Buy
ROC
-23.08
Sell
Prostatype Genomics AB’s (PGO0) Relative Strength Index (RSI) is 53.65, creating a Neutral signal.
Prostatype Genomics AB’s (PGO0) Trend Strength Indicator (ADX) is 38.05, creating a Neutral signal.
Prostatype Genomics AB’s (PGO0) Commodity Channel Index (CCI) is -49.01, creating a Neutral signal.
Prostatype Genomics AB’s (PGO0) Price Rate of Change (ROC) is -23.08, creating a Sell signal.

FAQ

Is PGO0 a Buy, Hold, or Sell?
Based on PGO0’s technical indicators, PGO0 is a Buy.
    What is PGO0’s RSI (14)?
    PGO0’s RSI (14) is 53.65, which suggests PGO0 is a Neutral.
      What is PGO0’s MACD?
      PGO0’s MACD is <0.01, which suggests PGO0 is a Buy.
        What is PGO0’s 5-day moving average?
        PGO0’s 5-day moving average is 0.10, which suggests PGO0 is a Sell.
          What is PGO0’s 20-day moving average?
          PGO0 20-day moving average is 0.11, which suggests PGO0 is a Sell.
            What is PGO0’s 50-day moving average?
            PGO0’s 50-day moving average is 0.07, which suggests PGO0 is a Buy.
              What is PGO0’s 200-day moving average?
              PGO0’s 200-day moving average is 0.06, which suggests PGO0 is a Buy.
                What is PGO0’s Williams % R (14)?
                PGO0’s Williams % R (14) is -45.24, which suggests PGO0 is a Buy.
                  What is PGO0’s CCI (14)?
                  PGO0’s CCI (14) is -49.01, which suggests PGO0 is a Neutral.
                    What is the share price of Prostatype Genomics AB?